Physician profile
Joseph G Mccabe
NPI 1174542500
$9,323.21
in general payments reported to CMS, 2019-2025
57 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $676 · 2021: $1,633 · 2022: $1,541 · 2023: $1,830 · 2024: $1,274 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,457.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,214.47 | 2021-2025 | |
| Amgen INC. | $1,209.00 | 2019-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $1,022.18 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $798.62 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $715.25 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $613.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $310.70 | 2019-2025 | Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $292.83 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.17 | 2019-2025 | Jardiance |
| Preventric Diagnostics, INC. | $222.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $217.09 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $210.23 | 2019-2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $193.73 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $146.85 | 2019-2023 | Seglentis, Livalo |
| Abbott Laboratories | $144.32 | 2021-2023 | Freestyle Libre 3 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.